Research Article

Assessment of cardiovascular and renal functions during treatment with Desmodium adscendens therapy

Seriki Samuel Adinoyi*

Published: 06/09/2020 | Volume 5 - Issue 2 | Pages: 114-120

Abstract

Desmodium adscendens is a rain forest medicinal herb used in managing quite a number of medical conditions. Its efficacy in the treatment of several diseases has made it a first line herb for doctors, especially in managing all forms of spasm. It is however common knowledge that some of these medicinal herbs impact severely on the normal functioning of some vital organs of the body during their administration. The present study was carried out to assess the renal and cardiovascular performance in subjects undergoing treatment with Desmodium adscendens with a view to advising against its indiscriminate use. The parameters used for the assessment of renal functions were serum creatinine and urea concentrations and their clearance. Also, changes in electrolyte concentration of Sodium, Potassium and Chloride concentration were used to assess cardiovascular performance. The histology of the kidney and heart tissues was also done to determine if the extract has impact on the cyto-architecture of the organs. Twenty-four (24) wistar rats were used for the experiment. The rats were grouped randomly into four groups (n = 6). Group 1 served as control, and the rats in the group were given normal rat feeds and water. Group 2 served as low dose group, and rats in this group were administered with low dose of extract 300 mg/kg. Group 3 served as medium group, and rats in this group were treated with medium dose of extract, 450 mg/kg. Group 4 served as high dose group, and rats in this group were treated with high dose of extract 600 mg/kg. The extract was administered for 28 days. Result showed that the extract did not impact negatively on the normal function of the renal and cardiovascular system of the treated groups, rather it enhanced their performances. It can therefore be concluded that the extract is beneficial to renal and cardiovascular functions if used within the treatment dosage.

Read Full Article HTML DOI: 10.29328/journal.jccm.1001097 Cite this Article

References

  1. Taylor L. The healing power of rainforest herbs. Square One Publishers. USA. 2005; 528.
  2. Evans WC. Trease and Evans Pharmacognosy. 15th edition, W.B. Sanders London. 2002; 419: 214-393.
  3. Addy ME. Some Secondary Plant Metabolites in Desmodium Adscendens and their effects on Anaihidonic Acid Metabolism. Prostaglandins Leukotrienes Essent. Fatty Acids. 1997; 47: 85-91. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1438471
  4. Seriki SA, Odetola OA, Adebayo OF. Analysis of Phytoconstituents of Desmodium adscendens in Relation to its Therapeutic Properties. Am J Biomed Sci Res. 2019; 249 .
  5. Ferenbach DA, Bonventre JV. Acute kidney injury and chronic kidney disease: from the laboratory to the clinic. Nephrologie & Therapeutique. 2016; 12(suppl 1): S41-S48. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5475438/
  6. Kellum JA, Lameire N. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements. 2012: 2: suppl1.
  7. Levey AS, Inker LA. Definition and staging of chronic kidney disease in adults. Up To Date. 2018. https://www.uptodate.com/contents/definition-and-staging-of-chronic-kidney-disease-in-adults
  8. Miltuninovic J, Cutler R, Hoover P, Meijsen B, Scribner B. Measurement of residual glomerular filtration rate in the patient receiving repetitive hemodialysis. Kidney Int. 1975; 8: 185–190. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1177378
  9. Kurzer F. Urea in the history of organic chemistry: Isolation from natural sources. J Chem Educ. 1956; 33, 9: 452-59.
  10. Baum N. Blood urea nitrogen and serum creatinine. Urology. 1975; 5, 5: 583-588. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1093306
  11. Maroni B, Steinman T, Mitch W. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int. 1985; 27: 58-65. PubMed: https://pubmed.ncbi.nlm.nih.gov/3981873
  12. Adinoyi SS, Oluwagbamila OB, Ademola AO. Role of Moringa oleifera on Electrolytes Levels and Cardiovascular Function in Human. Therapeutic Adv Cardiol. 2017; 1: 80-86.
  13. Endemann DH, Pu Q, De Ciuceis C, Savoia C, Virdis A, et al. Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment. Hypertension. 2004; 43: 399-404. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/14707158
  14. Huang A, Luethi N, Martensson J, Bellomo R, Cioccari L. Pharmacodynamics of intravenous frusemide bolus in critically ill patients. Critical Care Resuscitation. 2017; 19: 142–149. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28651510
  15. Asano S, Kato E, Yamauchi M, Ozawa Y, Iwasa M. The mechanism of acidosis caused by infusion of saline solution. Lancet. 1966; 1: 1245–1246. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/4161214
  16. Shires GT, Holman J. Dilution acidosis. Ann Intern Med. 1948; 28: 557–559. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18905223
  17. Trease GE, Evans WC. Pharmacognosy 12th Ed. 1984. Bailliere Tindal, London: 622.
  18. Hald PM. The flame photometer for the measurement of sodium and potassium in biological materials. J Biol Chemistry 1946; 167: 499 – 510. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20285045
  19. Molitch ME, Rodman E, Hirsch CA, Dubinsky E. Spurious serum creatinine elevations in ketoacidosis. Ann Intern Med. 1980; 93: 280–281. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/6773457
  20. Miltuninovic J, Cutler R, Hoover P, Meijsen B, Scribner B. Measurement of residual glomerular filtration rate in the patient receiving repetitive hemodialysis. Kidney Int. 1975; 8: 185–190. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1177378
  21. Andreev E. A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible? J Intern Med. 1999; 246: 247-252. PubMed: https://pubmed.ncbi.nlm.nih.gov/10475992
  22. Maroni B, Steinman T, Mitch W. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int. 1985; 27: 58-65. PubMed: https://pubmed.ncbi.nlm.nih.gov/3981873
  23. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999; 55: 648–658. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9987089
  24. Angeles C, Lane BP, Miller F, Nord EP. Fenofibrate-associated reversible acute allograft dysfunction in 3 renal transplant recipients: biopsy evidence of tubular toxicity. Am J Kidney Dis. 2004; 44: 543–550. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15332227